USC Neurologist Patrick Lyden, MD, principal investigator of 3K3A-APC Phase 3 clinical trial
Credit
USC/Don Milci
Usage Restrictions
none
License
Original content
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.